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Alteration of host cell ubiquitination
by the intracellular bacterial
pathogen Coxiella burnetii
Lindsey E. Pritchett* and Daniel E. Voth†
ABSTRACT
The intracellular bacterial agent of Q fever, Coxiella burnetii, replicates within a phagolysosomelike parasitophorous vacuole (PV) in human macrophages and delivers effector proteins to the
host cytosol via a Dot/Icm type IV secretion system (T4SS). The T4SS effectors are critical for
PV formation and prevention of host cell death that allows sufficient time for bacterial replication. Recruitment of ubiquitin-related components to the C. burnetii PV is also predicted to be
involved in PV formation and bacterial replication and is likely controlled by effector proteins.
In this study, we assessed the role of the Dot/Icm T4SS in regulating ubiquitination by comparing subcellular localization of ubiquitinated proteins between cells infected with C. burnetii and
a mutant that lacks a functional T4SS. Fluorescence microscopy showed ubiquitinated proteins
surrounding wild-type C. burnetii PV but not phagosomes harboring T4SS-defective organisms.
Immunoblot analysis showed altered ubiquitinated protein profiles throughout infection, suggesting C. burnetii impacts post-translational modification of host cell and/or bacterial proteins.
Future studies will determine how T4SS-mediated recruitment of ubiquitinated proteins impacts
C. burnetii-host cell interactions and eventual development of disease.

* Lindsey Pritchett is a May 2014 Honors graduate with a major in Poultry Science.
† Daniel E. Voth is a faculty mentor and assistant professor in the Department of Microbiology and Immunology at the
University of Arkansas for Medical Sciences.
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INTRODUCTION
Ubiquitination is a post-translational protein modification used by eukaryotic cells to control protein fate and
location. This three-step process begins with free ubiquitin binding to the E1 ubiquitin-activating enzyme followed by transfer of activated ubiquitin to the E2 ubiquitin-conjugating enzyme. Finally, the ubiquitin molecule
is either tethered to its target substrate directly by the E3
ubiquitin-protein ligase or using an E3 adaptor that binds
to E2 and the substrate. Eukaryotes encode two E1 proteins, 37 E2 proteins, and over 600 E3 ligases, providing
specificity (Komander, 2009). Two general types of ubiquitination can occur and have distinct effects on protein
activity. Mono-ubiquitination acts as a protein-targeting
signal and often guides plasma membrane-associated
proteins to endosomes (Hicke and Dunn, 2003; Patel et
al., 2009; Collins and Brown, 2010). Poly-ubiquitination
targets proteins to the 26S proteasome or lysosomes for
degradation (Thrower et al., 2000; Chen and Sun, 2009).
Poly-ubiquitination is typically controlled by the Skp1Cul1-F-box (SCF) complex that functions as an E3 ligase
(Jackson and Eldridge, 2002).
Many intracellular pathogens exploit host ubiquitination to alter host or bacterial protein stability and
function. For example, Listeria monocytogenes secretes a
pore-forming toxin known as listeriolysin O (LLO) that
lyses endosomal membranes, allowing bacterial escape

to the host cell cytoplasm and subsequent replication.
The LLO is then ubiquitinated for degradation to avoid
destroying the host cell (Collins and Brown, 2010). Salmonella typhimurium uses a needle-like type III secretion
system (TTSS) to secrete effector proteins, such as SopB,
into the host cytosol. In the cytosol, SopB promotes bacterial replication following mono-ubiquitination (Collins
and Brown, 2010). Legionella pneumophila also secretes
effector proteins, via a Dot/Icm type IV secretion system
(T4SS), which interact with ubiquitination machinery.
Poly-ubiquitinated proteins also accumulate on wild-type
L. pneumophila vacuoles (Ivanov and Roy, 2009).
Coxiella burnetii is an intracellular, Gram-negative
bacterium that causes the zoonosis human Q fever. Humans are typically infected with C. burnetii following
inhalation of contaminated aerosols while working with
infected livestock (Marrie, 1990). Q fever presents acutely as a flu-like illness, but can also persist chronically,
causing life-threatening endocarditis. Due to the flu-like
nature of acute Q fever symptoms, many cases are misdiagnosed. However, C. burnetii has the potential for use
as a biological weapon due to a low infectious dose (<10
organisms), aerosol-mediated transmission, and pronounced environmental stability (Williams, 1991; Gilk
et al., 2009). As a United States Center for Disease Control and Prevention category B select agent, the organism
warrants extensive research. Additionally, the number of
Q fever cases is on the rise worldwide and a better under-
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standing of pathogenic mechanisms is needed to identify
new therapeutics.
In vivo, C. burnetii displays tropism for alveolar macrophages and thrives within a lysosome-like compartment
termed the parasitophorous vacuole (PV). The PV formation and maturation occurs through the normal phagolysosomal pathway. The phagosome fuses with host autophagosomes, recruits GTPases (guanosine triphosphate
hydrolases) involved in vesicle fusion (Rab5 and Rab7), and
eventually acquires lysosomal hydrolases following lysosome fusion with the expanding vacuole. After maturation
to a phagolysosome, the PV expands and is maintained
by proteins that interact with the host cell following T4SSmediated translocation to the cytosol (Gilk et al., 2009).
Two recently identified T4SS effectors co-localize with
ubiquitinated proteins when expressed in human epithelioid carcinoma (HeLa) cells, suggesting the pathogen
interacts with host ubiquitin machinery. CpeC (Coxiella
plasmid effector protein C) is an effector protein that contains an F-box domain, which is part of the three-component SCF ubiquitination complex in eukaryotic cells
(Voth et al., 2011). CpeL (Coxiella plasmid effector protein L) was also recently identified as an effector protein
that co-localizes with ubiquitinated proteins (Maturana
et al., 2013). To test the hypothesis that C. burnetii uses
T4SS effectors, such as CpeC and CpeL, to exploit host
cell ubiquitin machinery, we compared subcellular localization of ubiquitinated proteins between cells infected
with wild-type C. burnetii and a mutant that lacks a functional T4SS.

MATERIALS AND METHODS
Bacteria and Mammalian Cell Culture. Avirulent C.
burnetii (Nine Mile phase II, clone RSA439) and a mutant strain with a disrupted icmD gene (Beare et al., 2011)
were used for infections in this study. Cells infected with
the IcmD mutant were grown in the presence of kanamy-

cin (375 μg/ml) for selection. The THP-1 human monocytic cells and HeLa cells were maintained in RPMI 1640
medium supplemented with 10% fetal bovine serum (FBS)
at 37 °C and 5% CO2. Prior to infection, THP-1 cells were
differentiated into macrophage-like cells by treatment with
phorbol 12-myristate 13-acetate (200 nM) for 24 h as
previously described (Voth et al., 2007). In the final portion of this study, HeLa cells were grown in the presence
of lactacystin (5 mM), a known proteasome inhibitor.
Immunofluorescence Microscopy. After infection of
THP-1 or HeLa cells with C. burnetii at a multiplicity of
infection ~10 for 4, 24, 48, 72, or 96 h, cells were fixed
and permeabilized with 4% paraformaldehyde for 15
min, then blocked for 1 h in phosphate buffered saline
(PBS) containing 0.5% bovine serum albumin (BSA)
and 0.3% Triton X-100 at room temperature. Cells were
then incubated at room temperature with either mouse
anti-FK1 antibody (1:100) or mouse anti-FK2 antibody
(1:250) and rabbit anti-C. burnetii antibody (1:1000) for
1 h. Cells were then washed three times with ice-cold
PBS and incubated for 1 h in 0.3% Triton X-100-0.5%
BSA-PBS containing AlexaFluor-488 or -594-conjugated
secondary antibodies at room temperature. Cells were
then washed twice with ice-cold PBS and incubated with
DAPI for 5 min at room temperature to detect host and
bacterial DNA. Fluorescence microscopy was performed
using a Nikon Ti-U microscope with a 60X oil immersion objective. Images were obtained with a D5-QilMc
digital camera and analyzed using NIS-Elements software. The PV were quantified from 5-10 fields, containing at least 10 cells/field. Wild-type PV were compared
to mutant-containing phagosomes at each time point.
Graphpad software was used for statistical analyses, and
significance of differences was assessed using a Student’s
t-test where P < 0.01.
Immunoblot Analysis. After infection of THP-1 cells for
4, 24, 48, or 72 h, cells were harvested in lysis buffer containing 1% sodium dodecyl sulfate (SDS) and total protein

Table 1. Antibody concentrations for western blot analysis.
Antibody
Host
Specificity
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anti-FK1

mouse

poly-ubiquitinated conjugates

anti-FK2

mouse

mono- and poly-ubiquitinated conjugates

anti-Skp1

rabbit

endogenous levels of total Skp1

anti-UBC3

rabbit

endogenous levels of total UBC3 and UBC3B

anti-K48

rabbit

poly-ubiquitin chains formed by Lys48 linkage

anti-K63

rabbit

poly-ubiquitin chains formed by Lys63 linkage
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concentration was determined using a detergent-compatible (DC) protein assay. Nine micrograms of total protein
was separated by SDS-polyacrylamide gel electrophoresis,
transferred to a polyvinylidene fluoride (PVDF) membrane, and immunoblotting was performed using mouse
antibodies directed against ubiquitin-related components
(1:1000; Table 1). Samples were also probed for equal
protein loading using a mouse antibody directed against
β-tubulin (1:1000). Reacting proteins were detected using either an anti-mouse or anti-rabbit secondary antibody conjugated to horseradish peroxidase (1:2000) and
enhanced chemiluminescence following exposure to
film. Densitometric analysis was performed to quantify
the amount of proteins resolved by SDS-PAGE.

RESULTS AND DISCUSSION
Recruitment of Ubiquitinated Proteins to the C. burnetii Parasitophorous Vacuole. To determine if C. burnetii
infection influences host ubiquitin processes, we first assessed whether ubiquitinated proteins are recruited to
the PV membrane similar to reports for other intracellular pathogen replication vacuoles (Ivanov and Roy, 2009;
Huang et al., 2012). Cells were assessed for ubiquitinated
protein localization over the course of a 96-h infection
using fluorescence microscopy (Fig. 1). Samples were incubated with FK1 antibody to detect poly-ubiquitinated
proteins or FK2 antibody to detect mono- and poly-ubiquitinated proteins. The FK1- and FK2-labeled proteins

Fig. 1. Recruitment of ubiquitinated proteins to the parasitophorous vacuole (PV). HeLa cells
were infected with wild type or T4SS-deficient (IcmD mutant) C. burnetii and prepared for
fluorescence microscopy at 4, 24, 48, 72, and 96 h post infection (hpi). 4’,6-diamidino-2phenylindole (DAPI) was used to stain DNA. FK1- (A) and FK2- (B) labeled proteins were
present on wild type PV (markers) from 24-96 hpi and fewer mutant-containing phagosomes.
Statistical analysis was performed using a Student’s t-test. Asterisks indicate significant
differences where P < 0.01.
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Fig. 2. Alteration of ubiquitinated protein levels in C. burnetii-infected cells. THP-1 human
monocytic cells were infected with wild type or IcmD mutant C. burnetii and cellular lysates
harvested at 4, 24, 48, and 72 hpi. Lysates were assessed for ubiquitinated protein levels by
immunoblot, and β-tubulin was probed to ensure equal protein loading.

were present on wild-type PV at all time points of infection with 40-60% of wild-type PV decorating with FK1and FK2-labeled proteins by 96 h post infection (hpi) on
average. In contrast, when averaged over all time points,
only 10-20% of IcmD mutant-containing phagosomes
associated with these proteins. These results indicate that
mono- and poly-ubiquitinated proteins are recruited to
the PV membrane in a T4SS-dependent fashion.
Of note, among wild-type C. burnetii-infected cells,
there was a high prevalence of large aggregations of ubiquitinated proteins. Similar structures, termed dendritic
cell aggresome-like structures (DALIS), have been previously observed around L. pneumophila-containing vacuoles (Ivanov and Roy, 2009). Thus, future studies will examine the formation and potential importance of DALIS
in C. burnetii-infected cells.
Alteration of Ubiquitinated Protein Levels During C.
burnetii Infection. Because ubiquitinated proteins were
recruited to the wild-type PV membrane, we next assessed
whether C. burnetii alters ubiquitinated protein profiles
using immunoblot analysis (Fig. 2). Levels of poly-ubiquitinated and mono-ubiquitinated proteins were analyzed
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using FK1 and FK2 antibodies, respectively. Over the course
of infection (4-72 hpi), overall levels of FK1-labeled proteins decreased while levels of FK2-labeled proteins increased in wild-type C. burnetii-infected cells. In contrast, levels of FK1- and FK2-labeled proteins remained
constant in IcmD mutant-infected cells. These results
suggest C. burnetii uses T4SS effectors to promote accumulation of mono-ubiquitinated proteins at 48 hpi and
beyond.
We next evaluated levels of Skp1, a critical component
of the SCF complex, and UBC3 throughout intracellular growth (Fig. 3). Density-based analysis confirmed
that levels of Skp1 decreased over the course of infection, while levels of UBC3 increased (data not shown).
These results correlate with accumulation of mono-ubiquitinated proteins at later times post-infection. We also
probed the presence of K48- and K63-linked proteins
during infection (Fig. 4). Differentiating these linkages
is important because they exert differing effects on target
protein function. The K48-linked poly-ubiquitin chains
serve proteolytic functions, while K63-linked chains are
involved in non-proteolytic functions similar to mono-
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Fig. 3. Alteration of ubiquitin-related components in C.
burnetii-infected cells. THP-1 human monocytic cells
were infected with wild type C. burnetii and cellular
lysates harvested at various time points post-infection.
Lysates were assessed for UBC3 and Skp1 levels by
immunoblot.

Fig. 4. K48- and K63-linked protein levels in C. burnetiiinfected cells. THP-1 human monocytic cells were
infected with wild type C. burnetii and whole cell lysates
were taken at 4, 24, 48, 72, and 96 hpi. Lysates were
assessed for levels of K-48 and K-63 linkages using
immunoblot, and β-tubulin was probed to ensure equal
protein loading.

ubiquitinated proteins. As infection progressed, K48linked protein levels decreased while K63-linked protein
levels increased. These results further suggest that C.
burnetii promotes accumulation of proteins involved in
cellular localization processes (mono-ubiquitination),
rather than proteasome-mediated degradation.
Proteasome inhibition does not affect infection progression. Previous results suggested that C. burnetii interacts with mono-ubiquitinated proteins. To assess the
potential importance of poly-ubiquitination during intracellular growth, we treated C. burnetii-infected cells
with lactacystin, a known proteasome inhibitor, and
monitored PV formation. When comparing treated cells
to untreated cells, there was no substantial change in PV
formation or the progression of infection (Fig. 5), further
suggesting mono-ubiquitination events are more important for C. burnetii manipulation of host cells.
In the current study, we show that a functional T4SS
is necessary for recruitment of ubiquitinated proteins to
the C. burnetii PV and alteration of ubiquitinated protein
levels. Ubiquitinated proteins label the PV only in wildtype C. burnetii-infected cells, suggesting ubiquitination
is involved in pathogenesis. Additionally, mono-ubiquitinated proteins and K63-linked poly-ubiquitin chains
accumulate during infection, suggesting C. burnetii manipulates host cell and/or bacterial protein trafficking.
Future studies will define a mechanism for T4SS-mediated recruitment of ubiquitin machinery and the impact of

this event on C. burnetii-host interactions.
The decrease observed in poly-ubiquitinated proteins
from 24-72 hpi could be attributed to infection-specific
degradation. However, treatment of infected cells with
the proteasome inhibitor lactacystin does not alter PV
formation or bacterial replication. These results correspond to the presence of DALIS in wild-type C. burnetii-infected cells. A DALIS can extend the half-life of
poly-ubiquitinated proteins by preventing proteasomedirected degradation (Lelouard et al., 2004), and this
may benefit C. burnetii. DALIS contain masses of ubiquitinated proteins (Ivanov and Roy, 2009) and sequester
defective ribosomal products (DRiPs) targeted for degradation (Lelouard et al., 2004). Previous studies also
found the ubiquitin-related proteins E1 and E2 and the
C-terminus of an E3 ligase in DALIS. Cells infected with
closely-related T4SS-deficient L. pneumophila produce
DALIS, while organisms with a functional T4SS fail to
trigger DALIS formation. The T4SS-deficient L. pneumophila, however, fails to avoid lysosome fusion and is
degraded (Ivanov and Roy, 2009). In contrast to L. pneumophila, DALIS-like structures are present in wild-type
C. burnetii-infected cells, suggesting they are not detrimental to pathogen viability. Future studies will define
the role of DALIS formation in PV formation and C. burnetii parasitism of host cells.
In this study, we assessed the role of the Dot/Icm T4SS
in regulating ubiquitination by comparing subcellular lo-
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Fig. 5. Lactacystin treatment of wild type C. burnetii-infected cells. HeLa cells were
infected with wild type C. burnetii and prepared for fluorescence microscopy at 4, 24,
48, 72, and 96 hours post infection (hpi). DAPI was used to stain DNA and CD63
was used to label the PV.

calization of ubiquitinated proteins between cells infected
with C. burnetii and a mutant that lacks a functional T4SS.
Using immunofluorescence assays (IFA) we found the wildtype Coxiella burnetii PV were labeled with ubiquitinated
proteins at a higher frequency than mutant-containing
phagosomes. This indicates that recruitment of ubiquitinated proteins to the PV is T4SS-dependent. Additionally, we used immunoblot analysis to look at ubiquitinated
protein profiles. A decrease in FK1-labeled proteins and
an increase in levels of FK2-labeled proteins in wild-type
PV led us to the conclusion that C. burnetii potentially
promotes accumulation of mono-ubiquitinated proteins
during cellular growth. Assessing other ubiquitin-related
components further suggested that mono-ubiquitinated
proteins were being accumulated on wild-type PV. Treating infected cells with lactacystin, a known proteasome
inhibitor, had no visible effect on the ability of C. burnetii
to establish an infection. This even further suggests that
mono-ubiquitinated proteins are more important for
proper C. burnetii infection.
Overall, the data obtained from this study contribute
to increased understanding of the C. burnetii-host cell
dynamic and provide new ubiquitin-related hypotheses
for future testing. Specifically, the presence of DALIS in
infected cells represents a novel area of research in C. burnetii pathogenesis. Additionally, linking ubiquitin modulation to a specific T4SS effector(s) will establish novel
bacterial protein activity that could be targeted in design
of new therapeutic strategies. Designing new therapeutic
techniques is of utmost importance as C. burnetii is a potential bioterror agent.
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